AU2001295722A1 - Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin - Google Patents

Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin

Info

Publication number
AU2001295722A1
AU2001295722A1 AU2001295722A AU9572201A AU2001295722A1 AU 2001295722 A1 AU2001295722 A1 AU 2001295722A1 AU 2001295722 A AU2001295722 A AU 2001295722A AU 9572201 A AU9572201 A AU 9572201A AU 2001295722 A1 AU2001295722 A1 AU 2001295722A1
Authority
AU
Australia
Prior art keywords
aivlosin
poultry
prophylaxis
pigs
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295722A
Other languages
English (en)
Inventor
Michael John Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eco Animal Health Ltd
Original Assignee
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eco Animal Health Ltd filed Critical Eco Animal Health Ltd
Publication of AU2001295722A1 publication Critical patent/AU2001295722A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Feed For Specific Animals (AREA)
AU2001295722A 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin Abandoned AU2001295722A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0025556.2 2000-10-18
GBGB0025556.2A GB0025556D0 (en) 2000-10-18 2000-10-18 Treatment and prophylaxis of disease and infections of pigs and poultry
PCT/GB2001/004575 WO2002032233A2 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin

Publications (1)

Publication Number Publication Date
AU2001295722A1 true AU2001295722A1 (en) 2002-04-29

Family

ID=9901546

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295722A Abandoned AU2001295722A1 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin

Country Status (20)

Country Link
US (2) US20040082524A1 (es)
EP (1) EP1326599B1 (es)
JP (2) JP4335524B2 (es)
KR (2) KR100866021B1 (es)
CN (6) CN1853644B (es)
AR (2) AR031002A1 (es)
AT (1) ATE347888T1 (es)
AU (1) AU2001295722A1 (es)
BR (4) BR122013012291B1 (es)
CA (1) CA2425319C (es)
CY (1) CY1107480T1 (es)
DE (1) DE60125212T2 (es)
DK (1) DK1326599T3 (es)
ES (1) ES2278788T3 (es)
GB (1) GB0025556D0 (es)
MX (1) MXPA03003309A (es)
PL (1) PL221310B1 (es)
PT (1) PT1326599E (es)
RU (2) RU2310446C2 (es)
WO (1) WO2002032233A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315629D0 (en) * 2003-07-03 2003-08-13 Eco Animal Health Ltd New uses for antibiotic
GB0613952D0 (en) * 2006-07-13 2006-08-23 Eco Animal Health Ltd Antiviral agent
SI2043661T1 (sl) 2006-07-13 2015-02-27 Eco Animal Health Ltd Uporaba tilvalozina kot antivirusnega agensa
RU2487709C2 (ru) * 2011-06-01 2013-07-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия имени В.Я. Горина" (ФГБОУ БелГСХА им. В.Я. Горина) Композиционный препарат для лечения пневмонии поросят
EP2990034A4 (en) * 2013-04-22 2017-04-26 Obshchestvo S Ogranichennoy Otvetstvennostyu "Nanobiotekh" Antiseptic veterinary formulation and methods for use thereof
CN104127429A (zh) * 2014-07-28 2014-11-05 邳州正康生物技术有限公司 一种用于防治畜禽呼吸道疾病的饮水剂及其制备方法
CN104256168B (zh) * 2014-09-28 2016-05-11 山东新希望六和集团有限公司 一种猪功能性饲料及其制备方法
CN106361707B (zh) * 2016-09-30 2019-02-26 广东温氏大华农生物科技有限公司 一种酒石酸泰万菌素颗粒制剂及其制备方法
CN107625779A (zh) * 2017-10-19 2018-01-26 洛阳瑞华动物保健品有限公司 一种用于抑制猪蓝耳病病毒复制的药物制剂、药剂盒
CN118021765A (zh) * 2024-04-15 2024-05-14 中国农业科学院农业环境与可持续发展研究所 酒石酸泰万菌素纳米制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
JPS52139088A (en) * 1976-05-15 1977-11-19 Sanraku Inc Antibiotics tyrocin derivatives and their preparation
US4201843A (en) * 1975-08-01 1980-05-06 Sanraku Ocean Co., Ltd. Process for manufacturing tylosin derivatives
DK144084A (da) * 1983-03-03 1984-09-04 Lilly Co Eli Makrolid, dets fremstilling og anvendelse
US4559301A (en) * 1983-03-03 1985-12-17 Eli Lilly And Company Process for preparing macrocin derivatives
US4582822A (en) * 1984-10-09 1986-04-15 Eli Lilly And Company Antibiotic A80190, pharmaceutical compositions containing same and method of use
DE3725946A1 (de) * 1987-08-05 1989-02-16 Boehringer Ingelheim Vetmed Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung
SE9801742L (sv) * 1998-05-18 1999-11-19 Akzo Nobel Nv Användning av naturliga substanser innehållande tymol vid framställning av djurfoder
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents

Also Published As

Publication number Publication date
CY1107480T1 (el) 2013-03-13
BR122013012291B1 (pt) 2016-06-21
CN1771980A (zh) 2006-05-17
ES2278788T3 (es) 2007-08-16
EP1326599B1 (en) 2006-12-13
DK1326599T3 (da) 2007-04-10
JP5001234B2 (ja) 2012-08-15
PL221310B1 (pl) 2016-03-31
RU2007105450A (ru) 2008-08-20
BR122013012292B1 (pt) 2016-06-21
CN1803142A (zh) 2006-07-19
CN100471501C (zh) 2009-03-25
GB0025556D0 (en) 2000-12-06
KR20030046491A (ko) 2003-06-12
EP1326599A2 (en) 2003-07-16
DE60125212T2 (de) 2007-11-15
KR20090005287A (ko) 2009-01-13
BR122013012293B1 (pt) 2016-06-21
CN1803140A (zh) 2006-07-19
KR100866021B1 (ko) 2008-10-31
AR031002A1 (es) 2003-09-03
CA2425319A1 (en) 2002-04-25
CN1853644A (zh) 2006-11-01
MXPA03003309A (es) 2003-06-19
CA2425319C (en) 2010-01-05
BRPI0114703B1 (pt) 2016-07-05
US20060247184A1 (en) 2006-11-02
RU2454230C2 (ru) 2012-06-27
JP2008297316A (ja) 2008-12-11
ATE347888T1 (de) 2007-01-15
JP4335524B2 (ja) 2009-09-30
RU2310446C2 (ru) 2007-11-20
CN1853644B (zh) 2010-12-08
BR0114703A (pt) 2003-12-23
JP2004511498A (ja) 2004-04-15
CN1803141A (zh) 2006-07-19
AR098251A2 (es) 2016-05-18
CN1469742A (zh) 2004-01-21
US20040082524A1 (en) 2004-04-29
WO2002032233A3 (en) 2002-08-01
KR100919725B1 (ko) 2009-09-29
WO2002032233A2 (en) 2002-04-25
PT1326599E (pt) 2007-03-30
PL362085A1 (en) 2004-10-18
DE60125212D1 (de) 2007-01-25

Similar Documents

Publication Publication Date Title
EP1531828A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
HUP0301815A3 (en) Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2003279526A1 (en) Identifying and treating vaginal infections
AU2001295722A1 (en) Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
EP1416795A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES OF MITOCHONDRIA
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
HK1052643A1 (en) Use of pleuromutilin derivatives in the manufacture of a mediament for transdermal treatment of bacterial infections in humans and animals
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU1405001A (en) Treatment of diseases
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
GB0109332D0 (en) Treatment of young poultry
HUP0200466A3 (en) Lipoglycan compositions and methods of treating parasitic infections
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU1007401A (en) Treatment of respiratory diseases and infections
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
AU2001277429A1 (en) Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs
WO2001092331A8 (en) Compositions and methods for the treatment of immune related diseases
AU2002246544A1 (en) Antimicrobial quinolone derivatives and use of the same to treat bacterial infections